Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications

Kidney International

Volumn 51, Issue 3, 1997, Pages 901-907

  Cattran, Daniel C ^a   Pei, York ^b   Greenwood, Celia M T ^b   Ponticelli, Claudio ^b   Passerini, Patrizia ^b   Honkanen, Eero ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MODEL; PREDICTION; PRIORITY JOURNAL;

EID: 0030934029     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.127     Document Type: Article

References (52)

1. DONADIO JV, TORRES VE, VELOSA JA, WAGONER R, HOLLEY K, OKAMURA M, ILSTRUP D, CHU C: Idiopathic membranous nephropathy: The natural history of untreated patients. Kidney Int 33:708-715, 1988
2. RAMZY MH, CAMERON JS, TURNER DR, NEILD GH, OGG CS, HICKS J: The long-term outcome of idiopathic membranous nephropathy. Clin Nephrol 16:13-19, 1981
3. GLUCK MC, GALLO G, LOWENSTEIN J, BALDWIN DS: Membranous glomerulonephritis: Evolution of clinical and pathologic features. Ann Intern Med 78:1-12, 1973
4. DAVISON AM, CAMERON JS, KERR NS, OGG CS, WILKINSON RW: The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 22:61-67, 1984
5. NOEL LH, ZANETTI M, DROZ D, BARBANEL C: Long-term prognosis of idiopathic membranous glomerulonephritis. Am J Med 66:82-90, 1979
6. MURPHY BF, FAIRLEY KF, KINCAID-SMITH PS: Idiopathic membranous glomerulonephritis: Long-term follow-up in 139 cases. Clin Nephrol 30:175-181, 1988
7. FRANKLIN WZ, JENNINGS RB, EARLE DP: Membranous glomerulonephritis: Long-term serial observations on clinical course and morphology. Kidney Int 4:36-56, 1973
8. HONKANEN E: Survival in idiopathic membranous glomerulonephritis. Clin Nephrol 25:122-128, 1986
9. KIDA H, ASAMOTO T, YOKOYAMA H, TOMOSUGI N, HATTORI N: Long-term prognosis of membranous nephropathy. Clin Nephrol 25:64-69, 1986
10. ABE S, AMAGASAKI Y, KONISHI K, KATO E, IYORI S, SAKAGUCHI H: Idiopathic membranous glomerulonephritis: Aspects of geographical differences. J Clin Pathol 39:1193-1198, 1986
11. HOPPER J, TREW PA, BIAVA CG: Membranous nephropathy: Its relative benignity in women. Nephron 29:18-24, 1982
12. TU WH, PETITTI DB, BIAVA CG, TULUNAY O, HOPPER J: Membranous nephropathy: Predictors of terminal renal failure. Nephron 36:118-124, 1984
13. HAY NM, BAILEY RR, LYNN KL, ROBSON RA: Membranous nephropathy: A 19 years prospective study in 51 patients. N Zealand Med J 2:489-491, 1992
14. SIMON P, RAMEE MP, AUTULY V, LAURELLE E, CHARASSE C, CARN G, ANG KS: Epidemiology of primary glomerular disease in a French region. Variations according to period and age. Kidney Int 46:1192-1198, 1994
15. TSUKAHARA H, TAKAHASHI Y, YOSHIMOTO M, HAYASHI S, FUJISAWA S, SUEHIRO F, AKAISHI K, NOMURA Y, MORIKAWA IC, SUDO M: Clinical course and outcome of idiopathic membranous nephropathy in Japanese children. Pediatr Nephrol 7:387-391, 1993
16. MACTIER R, BOULTON-JONES JM, PAYTON CD, MCLAY A: The natural history of membranous nephropathy in the west of Scotland. Quart J Med 60:793-802, 1986
17. KLOUDA PT, MANOS J, ACHESON EJ, DYER PA, GOLDBY FS, HARRIS R, LAWLER W, MALLICK NP, WILLIAM G: Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet i:770-771, 1979
18. SACKS SH, NOMURA S, WARNER C, NAITO S, OGAHARA S, VAUGHAN R, BRIGGS D: Analysis of complement C4 loci in Caucasoids and Japanese with idiopathic membranous nephropathy. Kidney InT 4:882-887, 1992
19. SACKS SH, WARNER C, CAMPBELL RD, DUNHAM I: Molecular mapping of the HLA class II region in HLA-DR3 associated idiopathic membranous nephropathy. Kidney Int 43(Suppl 39):S13-S19, 1993
20. OGAHARA S, NAITO S, ABE K, MICHINAGA I, ARAKWA K: Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis. Kidney Int 41:175-182, 1992
21. DYER PA, SHORT CD, CLARKE EA, MALLICK NP: HLA antigen and gene polymorphisms and haplotypes established by family studies in membranous nephropathy. Nephrol Dial Transplant (Suppl 1):42-47, 1992
22. SCHIEPPATI A, MOSCONI L, PERNA A, MECCA G, BERTANI T, GARATTINI S, REMUZZI G: Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 329:85-89, 1993
23. PICCOLI A, PILLON L, PASSERINI P, PONTICELLI C: Therapy for idiopathic membranous nephropathy: Tailoring the choice by decision analysis. Kidney Int 45:1193-1202, 1994
24. CAMERON JS: Membranous nephropathy-Still a treatment dilemma. (Editorial) N Engl J Med 327:638-639, 1992
25. LEWIS EJ: Idiopathic membranous nephropathy-To treat or not to treat. (Editorial) N Engl J Med 329:127-129, 1993
26. HUNT LP, SHORT CD, MALLICK NP: Prognostic indicators in patients presenting with the nephrotic syndrome. Kidney Int 34:382-388, 1988
27. SHEEHE PR: Prognostic modeling of clinical outcomes: An illustration with data from patients with membranous nephropathy. Epidemiology 2:339-347, 1991
28. PEI Y, CATTRAN DC, GREENWOOD C: Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 42:960-966, 1992
29. HONKANEN E, TORNROTH T, GRONHAGEN-RISKA C, SANKILA R: Long-term survival in idiopathic membranous glomerulonephritis: Can the course be clinically predicted? Clin Nephrol 41:127-134, 1994
30. CENTRAL COMMITTEE OF THE TORONTO GLOMERULONEPHRITIS REGISTRY: Regional program for the study of glomerulonephritis. Can Med Assoc J 124:158-161, 1984
31. MILLER ME, HUI SL, TIERNEY WM: Validation techniques for logistic regression models. Stat in Med 10:1213-1226, 1991
32. HARRELL FE, CALIFF RM, PRYOR DB, LEE KL, ROSATI RA: Evaluating the yield of medical tests. JAMA 247:2543-2546, 1982
33. COLLABORATIVE STUDY OF THE ADULT IDIOPATHIC NEPHROTIC SYNDROME: A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 301:1301-1306, 1979
34. CATTRAN DC, DELMORE T, ROSCOE J, COLE E, CARDELLA C, CHARRON R, RITCHIE S: A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 320:210-215, 1989
35. CAMERON JS, HEALY MJ, ADU D: The medical research council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. Quart J Med 74:133-156, 1990
36. PONTICELLI C, ZUCCHELLI P, IMBASCIATI E, CAGNOLI L, POZZI C, PASSERINI P, GRASSI C, LIMIDO D, PASQUALI S, VOLPINI T, SASDELLI M, LOCATELLI F: Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 310:946-950, 1984
37. PONTICELLI C, ZUCCHELLI P, PASSERINI P, CAGNOLI L, CESANA B, POZZI C, PASQUALI S, IMBASCIATI E, GRASSI C, REDAELLI B, SASDELLI M, LOCATELLI F: A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320:8-13, 1989
38. PONTICELLI C, ZUCCHELLI P, PASSERINI P, CESANA B, THE ITALIAN IDIOPATHIC MEMBRANOUS NEPHROPATHY TREATMENT STUDY GROUP: Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med 327:599-603, 1992
39. ALEXOPOULOS E, SAKELLARIOU G, MEMMOS D, KARAMITSOS K, LEONSTINI M, PAPADIMITRIOU M: Cyclophosphamide provides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy. Am J Kid Dis 21:497-503, 1993
40. REICHERT LJM, HUYSMANS FTM, ASSMANN K, KOENE RAP, WETZELS JFM: Preserving renal function in patients with membranous nephropathy: Daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide. Ann Intern Med 121:328-333, 1994
41. KIBRIYA MG, TISHKOV I, NIKOLOV D: Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy. Nephrol Dial Transplant 9:138-143, 1994
42. BRUNKHORST R, WRENGER E, KOCH KM: Low-dose prednisolone/ chlorambucil therapy in patients with severe membranous glomerulonephritis. Clin Invest 72:277-282, 1994
43. WARWICK GL, GEDDES CG, BOULTON-JONES JM: Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure. Quart J Med 87:223-229, 1994
44. BRUNS FJ, ALDER S, FRALEY DS, SEGEL DP: Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone. Ann Intern Med 114:725-730, 1991
45. JINDAL K, WEST M, BEAR R, GOLDSTEIN M: Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function. Am J Kidney Dis 19:61-67, 1992
46. FALK RJ, HOGAN SL, MULLER E, JENNETTE JC, THE GLOMERULAR DISEASE COLLABORATIVE NETWORK: Treatment of progressive membranous glomerulopathy: A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. Ann Intern Med 116:438-445, 1992
47. CATTRAN DC, GREENWOOD C, RITCHIE S, BERNSTEIN K, CHURCHILL D, CLARK WF, MORRIN P, LAVOIE S, FOR THE CANADIAN GLOMERULONEPHRITIS STUDY GROUP: A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int 47: 1130-1135, 1995
48. INOUYE SK, VISCOLI CM, HORWITZ RI, HURST LD, TINETTI ME: A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 119:474-481, 1993
49. MARK DB, LAM LC, LEE KL, CLAPP-CHANNING NE, WILLIAMS RB, PRYOR DB, CALIFF RM, HLTAKY MA: Identification of patients with coronary disease at high risk for loss of employment. Circulation 86:1485-1494, 1992
50. TALCOTT JA, SIEGEL RD, FINDER R, GOLDMAN L: Risk Assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule. J Clin Oncol 10:316-322, 1992
51. DICKSON ER, MURTAUGH PA, WIESNER RH, GRAMBSCH P, FLEMING TR, LUDWIG J, LARUSSO N, MALINCHOC M, CHAPMAN R, KAPLAN M, MADDREY W, WILLIAMS R, FARRANT M, LANGWORTHY A: Primary sclerosing cholangitis: Refinement and validation of survival models. GastroenterologY 103:1893-1901, 1992
52. COIFFIER B, GISSELBRECHT C, VOSE JM, TILLY H, HERBRECHT R, BOSLY A, ARMITAGE J: Prognostic factors in aggressive malignant lymphomas: Description and validation of a prognostic index that could identify patients requiring a more intensive therapy. J Clin Oncol 9:211-219, 1991